Top

Published in:

Open Access 01-02-2025 | Rheumatoid Arthritis | Observational Research

Self-management behaviors do not affect remission but mediate between mental health and disease outcomes in a longitudinal study of rheumatoid arthritis

Authors: Melissa Sweeney, Lewis Carpenter, Savia de Souza, Emma Caton, James Galloway, Andrew Cope, Mark Yates, Elena Nikiphorou, Sam Norton

Published in: Rheumatology International | Issue 2/2025

Abstract

Mental health has been shown to impact rheumatoid arthritis (RA) outcomes and is associated with self-management behaviors. The extent to which mental health impacts outcomes via different self-management behaviours has not been thoroughly investigated. Adult RA patients who were starting a new medication or dosage were recruited to a prospective cohort with follow-ups at 3 and 12-months covering clinical and patient-reported outcomes. The longitudinal relationships between mental health, self-management behaviors (diet, physical activity, sleep, smoking, alcohol, and medication nonadherence), disease outcome, and function were assessed. Self-management behaviors were considered mediators of mental health at baseline on outcomes at 3 and 12 months. Depression did not worsen the odds of EULAR response for the total PHQ at 3 months (OR = 0.96, p = 0.36) or 12 months (OR = 0.99, p = 0.99) nor for the categorical PHQ at 3 months (OR = 0.64, p = 0.34) or 12 months (OR = 0.67, p = 0.44). Anxiety also did not worsen the odds of EULAR response for the total GAD at 3 months (OR = 0.98, p = 0.76) or 12 months (OR1.04, 0.53) nor for the categorical GAD at 3 months (OR = 0.99, p = 0.99) or 12 months (OR = 0.94, p = 0.75). However, depression was associated with the DAS-28 at 3 months (b = 0.22, p = 0.04). Among the self-management behaviors, insomnia was found to be a significant mediator between depression and the WSAS (b = 0.08, p = 0.03) as well as anxiety and the WSAS (b = 0.07, p = 0.03). Alcohol was also a significant mediator between depression and the DAS-28 (b = 0.21, p = 0.04). Mental health was associated with worse quality of life and disease outcomes, but not EULAR response. Self-management behaviors were associated with disease outcomes and mental health.

Available only for authorised users

Abhishek A, Doherty M, Kuo CF, Mallen CD, Zhang W, Grainge MJ (2017) Rheumatoid arthritis is getting less frequent-Results of a nationwide population-based cohort study. Rheumatol (United Kingdom) 56(5):736–744. https://doi.org/10.1093/rheumatology/kew468CrossRef

Matcham F, Scott IC, Rayner L et al (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis. Semin Arthritis Rheum 44(2):123–130. https://doi.org/10.1016/j.semarthrit.2014.05.001CrossRefPubMed

Abdelrahman MSI, Shaddad AM, Khaleel WGE, Talaat EA, Safwat SM, Farrag S (2024) Sleep quality, anxiety, depression, and quality of life in rheumatoid arthritis patients and impact of disease activity. Egypt Rheumatol Rehabil 51(1). https://doi.org/10.1186/s43166-024-00242-z

K W, N P (2019) Depression and anxiety in patients with rheumatoid arthritis. Ann Rheum Dis 78(Supplement 2):1623. https://doi.org/10.1136/annrheumdis-2019-eular.3169CrossRef

Norton S, Sacker A, Young A, Done J (2011) Distinct psychological distress trajectories in rheumatoid arthritis: Findings from an inception cohort. J Psychosom Res 71(5):290–295. https://doi.org/10.1016/j.jpsychores.2011.05.006CrossRefPubMed

Covic T, Cumming SR, Pallant JF et al (2012) Depression and anxiety in patients with rheumatoid arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 12. https://doi.org/10.1186/1471-244X-12-6

Choy EH (2019) Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis. Rheumatol (United Kingdom) 58:V51–V55. https://doi.org/10.1093/rheumatology/kez389CrossRef

Tanaka Y, Ikeda K, Kaneko Y, Ishiguro N, Takeuchi T (2024) Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis. Expert Rev Clin Immunol 20(5):485–499CrossRefPubMed

Roodenrijs NMT, Kedves M, Hamar A et al (2021) Diagnostic issues in difficult-to-treat rheumatoid arthritis: A systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open 7(1):1–16. https://doi.org/10.1136/rmdopen-2020-001511CrossRef

10.

Vestergaard SB, Esbensen BA, Klausen JM et al (2024) Prevalence of anxiety and depression and the association with self-management behaviour in > 12 000 patients with inflammatory rheumatic disease: a cross-sectional nationwide study. RMD Open 10(1):1–11. https://doi.org/10.1136/rmdopen-2023-003412CrossRef

11.

Matcham F, Norton S, Scott DL, Steer S, Hotopf M (2016) Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford) 55(2):268–278. https://doi.org/10.1093/rheumatology/kev306CrossRefPubMed

12.

Matcham F, Davies R, Hotopf M et al (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register. Rheumatol (United Kingdom) 57(5):835–843. https://doi.org/10.1093/rheumatology/kex528CrossRef

13.

Bechman K, Sin FE, Ibrahim F et al (2018) Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: An exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial. RMD Open 4(1). https://doi.org/10.1136/rmdopen-2018-000676

14.

Shao JH, Yu KH, Chen SH (2021) Effectiveness of a self-management program for joint protection and physical activity in patients with rheumatoid arthritis: A randomized controlled trial. Int J Nurs Stud 116:103752. https://doi.org/10.1016/j.ijnurstu.2020.103752CrossRefPubMed

15.

Stumper N, Berger J, Failli V et al (2023) Op0175 Relevant Features in Fluorescence Optical Imaging for Differential Diagnosis of Rheumatic Diseases Affecting the Hands. Ann Rheum Dis 82(Suppl 1):115. https://doi.org/10.1136/annrheumdis-2023-eular.5051CrossRef

16.

Gilek-Seibert K, Prescott K, Kazi S (2013) Outcome assessments in rheumatoid arthritis. Curr Rheumatol Rep 15(11). https://doi.org/10.1007/s11926-013-0370-y

17.

Huskisson EC (1974) Measurement of Pain. Lancet ii:1127–1131CrossRef

18.

Rohekar G, Pope J (2009) Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis. J Rheumatol 36(10):2178–2182. https://doi.org/10.3899/jrheum.090084CrossRefPubMed

19.

Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP (2011) Validity of four pain intensity rating scales. Pain 152(10):2399–2404. https://doi.org/10.1016/j.pain.2011.07.005CrossRefPubMed

20.

Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. J Gen Intern Med 46202:606–613CrossRef

21.

Spitzer RL, Kroenke K, Williams JBW, Löwe B (2006) A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 166(10):1092–1097. https://doi.org/10.1001/archinte.166.10.1092CrossRefPubMed

22.

Wells GA, Li T, Kirwan JR et al (2009) Assessing quality of sleep in patients with rheumatoid arthritis. J Rheumatol 36(9):2077–2086. https://doi.org/10.3899/jrheum.090362CrossRefPubMed

23.

Bastien CH, Vallières A, Morin CM (2001) Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2(4):297–307. https://doi.org/10.1016/S1389-9457(00)00065-4CrossRefPubMed

24.

Steultjens M, Bell K, Hendry G (2023) The challenges of measuring physical activity and sedentary behaviour in people with rheumatoid arthritis. Rheumatol Adv Pract 7(1). https://doi.org/10.1093/rap/rkac101

25.

Tierney M, Fraser A, Kennedy N (2015) Criterion validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF) for use in patients with rheumatoid arthritis: Comparison with the SenseWear Armband. Physiother (United Kingdom) 101(2):193–197. https://doi.org/10.1016/j.physio.2014.07.005CrossRef

26.

Craig CL, Marshall AL, Sjöström M et al (2003) International physical activity questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc 35(8):1381–1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FBCrossRefPubMed

27.

Bergman S, Symeonidou S, Andersson ML, Söderlin MK (2013) Alcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden: Data from BARFOT, a multicenter study on early RA. BMC Musculoskelet Disord 14. https://doi.org/10.1186/1471-2474-14-218

28.

Aronsson M, Bergman S, Lindqvist E, Andersson MLE (2022) Comparison of chronic widespread pain prevalence with different criteria in two cohorts of rheumatoid arthritis. Clin Rheumatol 41(4):1023–1032. https://doi.org/10.1007/s10067-021-05999-8CrossRefPubMed

29.

Reinert DF, Allen JP (2002) The Alcohol Use Disorders Identification Test (AUDIT): A Review of Recent Research. Alcohol Clin Exp Res 26(2):272–279CrossRefPubMed

30.

McKnight-Eily LR, Liu Y, Brewer RD et al (2014) Vital signs: communication between health professionals and their patients about alcohol use–44 states and the District of Columbia, 2011. MMWR Morb Mortal Wkly Rep 63(1):16–22. http://www.ncbi.nlm.nih.gov/pubmed/24402468%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5779334PubMedPubMedCentral

31.

Thompson FE, Subar AF (2009) Dietary Assessment Methods. https://doi.org/10.1093/acprof:oso/9780195312911.003.0006

32.

Petitti DB, Friedman GD, Kahn W (1981) Accuracy of information on smoking habits provided on self-administered research questionnaires. Am J Public Health 71(3):308–311. https://doi.org/10.2105/AJPH.71.3.308CrossRefPubMedPubMedCentral

33.

Morabia A, Bernstein MS, Curtin F, Berode M (2001) Validation of self-reported smoking status by simultaneous measurement of carbon monoxide and salivary thiocyanate. Prev Med (Baltim) 32(1):82–88. https://doi.org/10.1006/pmed.2000.0779CrossRef

34.

Williams AB, Amico KR, Bova C, Womack JA (2013) A proposal for quality standards for measuring medication adherence in research. AIDS Behav 17(1):284–297. https://doi.org/10.1007/s10461-012-0172-7CrossRefPubMedPubMedCentral

35.

Mundt JC, Marks IM, Shear MK, Greist JH (2002) The Work and Social Adjustment Scale: A simple measure of impairment in functioning. Br J Psychiatry 180(MAY):461–464. https://doi.org/10.1192/bjp.180.5.461CrossRefPubMed

36.

Thandi G, Fear NT, Chalder T (2017) A comparison of the Work and Social Adjustment Scale (WSAS) across different patient populations using Rasch analysis and exploratory factor analysis. J Psychosom Res 92:45–48. https://doi.org/10.1016/j.jpsychores.2016.11.009CrossRefPubMed

37.

Goyal S, Sudhir PM, Sharma MP (2020) Illness perceptions and health beliefs in persons with common mental disorders. Asian J Psychiatr 53(July):102366. https://doi.org/10.1016/j.ajp.2020.102366CrossRefPubMed

38.

Iacobucci D, Saldanha N, Deng X (2007) A meditation on mediation: Evidence that structural equations models perform better than regressions. J Consum Psychol 17(2):139–153. https://doi.org/10.1016/S1057-7408(07)70020-7CrossRef

39.

Dale H, Brassington L, King K (2014) The impact of healthy lifestyle interventions on mental health and wellbeing: A systematic review. Ment Heal Rev J 19(1):1–25. https://doi.org/10.1108/mhrj-05-2013-0016CrossRef

40.

Zaman R, Hankir A, Jemni M (2019) Lifestyle factors and mental health. Psychiatr Danub 31:217–220PubMed

41.

Marques A, Santos E, Nikiphorou E, Bosworth A, Carmona L (2021) Effectiveness of self-management interventions in inflammatory arthritis: A systematic review informing the 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. RMD Open 7(2):1–9. https://doi.org/10.1136/rmdopen-2021-001647CrossRef

42.

Iversen MD, Brawerman M, Iversen CN (2012) Recommendations and the state of the evidence for physical activity interventions for adults with rheumatoid arthritis: 2007 to present. Int J Clin Rheumtol 7(5):489–503. https://doi.org/10.2217/ijr.12.53CrossRefPubMedPubMedCentral

43.

Verhoeven F, Tordi N, Prati C, Demougeot C, Mougin F, Wendling D (2016) Physical activity and rheumatoid arthritis. Rev du Rhum (Edition Fr 83(2):99–104. https://doi.org/10.1016/j.rhum.2015.06.005CrossRef

44.

Thomsen T, Aadahl M, Hetland ML, Esbensen BA (2024) Physical activity guidance in the rheumatology clinic—what matters for patients with rheumatoid arthritis? A qualitative study. Rheumatol Int 44(1):181–189. https://doi.org/10.1007/s00296-023-05466-4CrossRefPubMed

45.

Nikiphorou E, Santos EJF, Marques A et al (2021) 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis 80(10):1278–1285. https://doi.org/10.1136/ANNRHEUMDIS-2021-220249CrossRefPubMed

46.

Sweeney M, Carpenter L, De Souza S et al (2022) The impact of COVID-19 on clinical care, self-management and mental health of patients with inflammatory arthritis. Rheumatol Adv Pract 6(1):1–12. https://doi.org/10.1093/rap/rkab095CrossRef

47.

Arora T, Grey I (2020) Health behaviour changes during COVID-19 and the potential consequences: A mini-review. J Health Psychol 25(9):1155–1163. https://doi.org/10.1177/1359105320937053CrossRefPubMed

48.

Demmelmaier I, Bergman P, Nordgren B, Jensen I, Opava CH (2013) Current and maintained health-enhancing physical activity in rheumatoid arthritis: A cross-sectional study. Arthritis Care Res 65(7):1166–1176. https://doi.org/10.1002/acr.21951CrossRef

49.

Westland H, Kuiper S, van den Bovenkamp C, Blaas E, Jaarsma T (2023) How do patients with rheumatoid arthritis perceive their self-care and self-care support? A mixed-method study. J Adv Nurs 2024;(September 4310–4322. https://doi.org/10.1111/jan.16103

Title: Self-management behaviors do not affect remission but mediate between mental health and disease outcomes in a longitudinal study of rheumatoid arthritis
Authors: Melissa Sweeney
Lewis Carpenter
Savia de Souza
Emma Caton
James Galloway
Andrew Cope
Mark Yates
Elena Nikiphorou
Sam Norton
Publication date: 01-02-2025
Publisher: Springer Berlin Heidelberg
Keywords: Rheumatoid Arthritis
Anxiety
Insomnia Disorders
Insomnia Disorders
Published in: Rheumatology International / Issue 2/2025
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-024-05761-8

Diversity of central nervous system manifestations in Sjogren’s Disease: a case-based review

Open Access
Primary Sjögren Syndrome
Case Based Review

Sexual dysfunction, anxiety, depression and reduced quality of life in women with non-radiographic axial spondyloarthritis– a cross-sectional analysis

Spondyloarthropathy
Observational Research

Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study

Open Access
Rheumatoid Arthritis
Observational Research

Patients with antiphospholipid antibodies preferentially seek health information from physicians: a cross-sectional online patient quantitative survey

Antiphospholipid Syndrome
Patient Opinion

Correction: Physical component of SF-36 is associated with measures of disease activity in patients with psoriatic arthritis: a real-life study from a tertiary referral centre

Psoriatic Arthritis
Correction

Severity of skin disease strongly correlates with quality of life in people with psoriatic arthritis: a systematic review

Psoriatic Arthritis
Systematic Review

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now

Keynote webinar | Spotlight on adolescent vaping

Pediatrics
On-demand webinar

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Please log in to get access to this content